Increased levels of physical activity after a diagnosis of prostate cancer are associated with significantly better survival, according to the results of a new, large prospective cohort study.
Pam Skurkay talks about when she and other nurses began using a medicine to treat bone-related health issues and how they eventually allowed outside medical offices the pre-authorization to use it.
Dianna Shafer and Angela Hunter talk about the DEXA scan results, and how the implementation of a specific therapy helped decrease bone-related issues.
Dianna Shafer talks about how bone health goes with prostate health treatment, and trying to avoid skeletal health events.
Pam Skurkay, Dianna Shafer, and Angela Hunter discuss the positive scan results they are seeing post-immunotherapy when using denosumab.
Both abiraterone and enzalutamide are approved by the US Food and Drug Administration for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Both drugs have different mechanisms of action and different adverse event profiles, but there are limited data comparing them directly.
Regular use of aspirin appeared to reduce the risk for dying from lethal prostate cancer in a large observational study reported at the 2016 Genitourinary Cancers Symposium.
Docetaxel Does Not Compromise Long-Term QOL in Men with Metastatic Hormone-Sensitive Prostate Cancer
Docetaxel added to androgen-deprivation therapy (ADT) improves survival for men with metastatic hormone-sensitive prostate cancer (mHSPC), as shown by the pivotal ECOG 3805 CHAARTED trial.
Active Holistic Surveillance Incorporates Diet, Supplements, Exercise for Low-Risk and Low-Intermediate–Risk Prostate Cancer
Men with low-risk prostate cancer are typically offered management with active surveillance, which entails regular office visits, digital rectal exam, MRI scans, prostate-specific antigen (PSA) testing, and prostate biopsy at physician-specified intervals.
Two pilot programs aimed at reducing the utilization of inappropriate testosterone replacement therapy, particularly in the treatment of men with age-related hypogonadism, have shown success in raising awareness of evidence and safety concerns.
Page 2 of 6
Results 11 - 20 of 54
Results 11 - 20 of 54